DE60144524D1 - Pharmazeutische zubereitung und methode diese zu verabreichen - Google Patents
Pharmazeutische zubereitung und methode diese zu verabreichenInfo
- Publication number
- DE60144524D1 DE60144524D1 DE60144524T DE60144524T DE60144524D1 DE 60144524 D1 DE60144524 D1 DE 60144524D1 DE 60144524 T DE60144524 T DE 60144524T DE 60144524 T DE60144524 T DE 60144524T DE 60144524 D1 DE60144524 D1 DE 60144524D1
- Authority
- DE
- Germany
- Prior art keywords
- sheath
- tissue
- micro
- active agent
- capsules
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/2853—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
- A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Dermatology (AREA)
- Addiction (AREA)
- Emergency Medicine (AREA)
- Psychiatry (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPQ9851A AUPQ985100A0 (en) | 2000-09-01 | 2000-09-01 | Method of administration of implants |
AUPQ9852A AUPQ985200A0 (en) | 2000-09-01 | 2000-09-01 | Slow release pharmaceutical preparation |
PCT/AU2001/001107 WO2002017971A1 (en) | 2000-09-01 | 2001-09-03 | Slow release pharmaceutical preparation and method of administering same |
Publications (1)
Publication Number | Publication Date |
---|---|
DE60144524D1 true DE60144524D1 (de) | 2011-06-09 |
Family
ID=25646428
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60144524T Expired - Lifetime DE60144524D1 (de) | 2000-09-01 | 2001-09-03 | Pharmazeutische zubereitung und methode diese zu verabreichen |
Country Status (9)
Country | Link |
---|---|
US (1) | US7914804B2 (de) |
EP (1) | EP1317304B1 (de) |
CN (2) | CN1468090A (de) |
AT (1) | ATE506942T1 (de) |
AU (2) | AU8734901A (de) |
CA (1) | CA2420854C (de) |
DE (1) | DE60144524D1 (de) |
HK (1) | HK1052310B (de) |
WO (1) | WO2002017971A1 (de) |
Families Citing this family (43)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100366249C (zh) * | 2002-09-29 | 2008-02-06 | 天津帝士力投资控股集团有限公司 | 一种替莫唑胺控释给药*** |
US20090208540A1 (en) * | 2003-08-11 | 2009-08-20 | Indevus Pharmaceuticals, Inc. | Implantable device for the delivery of naltrexone and methods of use thereof |
US7858110B2 (en) * | 2003-08-11 | 2010-12-28 | Endo Pharmaceuticals Solutions, Inc. | Long term drug delivery devices with polyurethane based polymers and their manufacture |
CA2437639C (en) * | 2003-08-11 | 2016-07-05 | Valera Pharmaceuticals, Inc. | Long term drug delivery devices with polyurethane based polymers and their manufacture |
CN1311817C (zh) * | 2005-05-13 | 2007-04-25 | 山东蓝金生物工程有限公司 | 一种治疗实体肿瘤的药物组合物 |
US20070009564A1 (en) * | 2005-06-22 | 2007-01-11 | Mcclain James B | Drug/polymer composite materials and methods of making the same |
US20090062909A1 (en) | 2005-07-15 | 2009-03-05 | Micell Technologies, Inc. | Stent with polymer coating containing amorphous rapamycin |
US8298565B2 (en) | 2005-07-15 | 2012-10-30 | Micell Technologies, Inc. | Polymer coatings containing drug powder of controlled morphology |
PL2019657T3 (pl) | 2006-04-26 | 2015-10-30 | Micell Technologies Inc | Powłoki zawierające wiele leków |
WO2008052000A2 (en) | 2006-10-23 | 2008-05-02 | Micell Technologies, Inc. | Holder for electrically charging a substrate during coating |
CA2679712C (en) | 2007-01-08 | 2016-11-15 | Micell Technologies, Inc. | Stents having biodegradable layers |
US11426494B2 (en) | 2007-01-08 | 2022-08-30 | MT Acquisition Holdings LLC | Stents having biodegradable layers |
WO2008148013A1 (en) | 2007-05-25 | 2008-12-04 | Micell Technologies, Inc. | Polymer films for medical device coating |
WO2009046299A2 (en) * | 2007-10-04 | 2009-04-09 | Boston Scientific Scimed, Inc | Implantable drug depot for intrathecal drug delivery system for pain management |
EP3360586B1 (de) | 2008-04-17 | 2024-03-06 | Micell Technologies, Inc. | Stents mit biologisch abbaubaren schichten |
AU2009270849B2 (en) | 2008-07-17 | 2013-11-21 | Micell Technologies, Inc. | Drug delivery medical device |
WO2011009096A1 (en) | 2009-07-16 | 2011-01-20 | Micell Technologies, Inc. | Drug delivery medical device |
RU2510266C2 (ru) * | 2008-09-30 | 2014-03-27 | Эндо Фармасьютикалз Солюшнз Инк. | Имплантируемое устройство для доставки рисперидона и способы его применения |
CA2739179A1 (en) * | 2008-09-30 | 2010-04-08 | Endo Pharmaceuticals Solutions Inc. | Implantable device for the delivery of histrelin and methods of use thereof |
US8834913B2 (en) | 2008-12-26 | 2014-09-16 | Battelle Memorial Institute | Medical implants and methods of making medical implants |
US9283212B2 (en) | 2009-02-20 | 2016-03-15 | Palmaya Pty Ltd | Pharmaceutical preparation and delivery system |
JP2012522589A (ja) | 2009-04-01 | 2012-09-27 | ミシェル テクノロジーズ,インコーポレイテッド | 被覆ステント |
WO2010121187A2 (en) | 2009-04-17 | 2010-10-21 | Micell Techologies, Inc. | Stents having controlled elution |
ES2434315T3 (es) * | 2009-12-22 | 2013-12-16 | Takeda Pharmaceutical Company Limited | Formulación de liberación sostenida |
WO2011097103A1 (en) | 2010-02-02 | 2011-08-11 | Micell Technologies, Inc. | Stent and stent delivery system with improved deliverability |
US8795762B2 (en) | 2010-03-26 | 2014-08-05 | Battelle Memorial Institute | System and method for enhanced electrostatic deposition and surface coatings |
CA2797110C (en) | 2010-04-22 | 2020-07-21 | Micell Technologies, Inc. | Stents and other devices having extracellular matrix coating |
WO2012009684A2 (en) | 2010-07-16 | 2012-01-19 | Micell Technologies, Inc. | Drug delivery medical device |
WO2012034079A2 (en) | 2010-09-09 | 2012-03-15 | Micell Technologies, Inc. | Macrolide dosage forms |
WO2012054815A1 (en) | 2010-10-22 | 2012-04-26 | Duke University | Slow-release formulations of 5-hydroxytryptophan as an adjunct to pro-serotonergic therapies |
US10464100B2 (en) | 2011-05-31 | 2019-11-05 | Micell Technologies, Inc. | System and process for formation of a time-released, drug-eluting transferable coating |
WO2013012689A1 (en) | 2011-07-15 | 2013-01-24 | Micell Technologies, Inc. | Drug delivery medical device |
US10188772B2 (en) | 2011-10-18 | 2019-01-29 | Micell Technologies, Inc. | Drug delivery medical device |
CN102512399B (zh) * | 2011-12-31 | 2013-05-01 | 湖南赛沃药业股份有限公司 | 一种长效纳曲酮植入剂及其制备方法 |
DE102012009057A1 (de) | 2012-05-09 | 2013-11-14 | Dr. Arabin GmbH & Co. KG | Rotationspessar mit zusätzlicher Wirkstoffkomponente |
AU2014248508B2 (en) | 2013-03-12 | 2018-11-08 | Micell Technologies, Inc. | Bioabsorbable biomedical implants |
JP2016519965A (ja) | 2013-05-15 | 2016-07-11 | マイセル・テクノロジーズ,インコーポレイテッド | 生体吸収性バイオメディカルインプラント |
PL3340968T3 (pl) * | 2015-08-24 | 2022-09-26 | Rusan Pharma Limited | Tabletki naltreksonu do implantacji |
AU2017439185B2 (en) * | 2017-11-08 | 2021-05-13 | Aquesys, Inc. | Manually adjustable intraocular flow regulation |
US11246753B2 (en) | 2017-11-08 | 2022-02-15 | Aquesys, Inc. | Manually adjustable intraocular flow regulation |
PL3866765T3 (pl) | 2018-10-15 | 2024-06-10 | Chong Kun Dang Pharmaceutical Corp. | Nadające się do wstrzykiwania długo działające kompozycje mikrocząstek naltreksonu |
CN110698656A (zh) * | 2019-10-12 | 2020-01-17 | 西安交通大学 | 一种低温熔融药物缓释医用高分子材料合成方法及应用 |
CN113509448A (zh) * | 2020-07-02 | 2021-10-19 | 安徽中医药大学 | 一种可生物降解控释长效植入片及其制备方法 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL280825A (de) | 1962-07-11 | |||
DE2010115A1 (de) * | 1970-03-04 | 1971-09-16 | Farbenfabriken Bayer Ag, 5090 Leverkusen | Verfahren zur Herstellung von Mikrogranulaten |
US4351337A (en) * | 1973-05-17 | 1982-09-28 | Arthur D. Little, Inc. | Biodegradable, implantable drug delivery device, and process for preparing and using the same |
GB1598458A (en) | 1977-04-01 | 1981-09-23 | Hoechst Uk Ltd | Tableting of microcapsules |
IN156886B (de) * | 1981-08-22 | 1985-11-30 | Council Scient Ind Res | |
US5183464A (en) | 1991-05-17 | 1993-02-02 | Interventional Thermodynamics, Inc. | Radially expandable dilator |
DE4223169C1 (de) * | 1992-07-10 | 1993-11-25 | Ferring Arzneimittel Gmbh | Verfahren zur Mikroverkapselung wasserlöslicher Wirkstoffe |
US5304119A (en) * | 1993-06-24 | 1994-04-19 | Monsanto Company | Instrument for injecting implants through animal hide |
WO1997027843A2 (en) * | 1996-01-30 | 1997-08-07 | Advanced Polymer Systems, Inc. | Targeted delivery of drugs to the lower gastrointestinal tract |
US5817343A (en) | 1996-05-14 | 1998-10-06 | Alkermes, Inc. | Method for fabricating polymer-based controlled-release devices |
US6203813B1 (en) * | 1997-01-13 | 2001-03-20 | Lance L. Gooberman | Pharmaceutical delivery device and method of preparation therefor |
BRPI9908893B8 (pt) * | 1998-03-19 | 2021-05-25 | Merck & Co Inc | composição polimérica líquida para a liberação controlada de substâncias bioativas hidrofóbicas. |
US6245052B1 (en) * | 1998-07-08 | 2001-06-12 | Innerdyne, Inc. | Methods, systems, and kits for implanting articles |
-
2001
- 2001-09-03 CA CA2420854A patent/CA2420854C/en not_active Expired - Lifetime
- 2001-09-03 AU AU8734901A patent/AU8734901A/xx active Pending
- 2001-09-03 US US10/363,107 patent/US7914804B2/en not_active Expired - Fee Related
- 2001-09-03 CN CNA018167438A patent/CN1468090A/zh active Pending
- 2001-09-03 WO PCT/AU2001/001107 patent/WO2002017971A1/en active Application Filing
- 2001-09-03 DE DE60144524T patent/DE60144524D1/de not_active Expired - Lifetime
- 2001-09-03 AT AT01966803T patent/ATE506942T1/de not_active IP Right Cessation
- 2001-09-03 CN CN201210405732.XA patent/CN102871979B/zh not_active Expired - Fee Related
- 2001-09-03 AU AU2001287349A patent/AU2001287349B2/en not_active Expired
- 2001-09-03 EP EP01966803A patent/EP1317304B1/de not_active Expired - Lifetime
-
2003
- 2003-06-20 HK HK03104444.1A patent/HK1052310B/zh not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
AU8734901A (en) | 2002-03-13 |
WO2002017971A1 (en) | 2002-03-07 |
CN102871979B (zh) | 2014-10-22 |
CA2420854C (en) | 2013-07-30 |
CN1468090A (zh) | 2004-01-14 |
AU2001287349B2 (en) | 2006-03-02 |
US7914804B2 (en) | 2011-03-29 |
HK1052310B (zh) | 2011-12-16 |
CA2420854A1 (en) | 2002-03-07 |
ATE506942T1 (de) | 2011-05-15 |
EP1317304B1 (de) | 2011-04-27 |
HK1052310A1 (en) | 2003-09-11 |
US20030170305A1 (en) | 2003-09-11 |
EP1317304A1 (de) | 2003-06-11 |
CN102871979A (zh) | 2013-01-16 |
EP1317304A4 (de) | 2005-11-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60144524D1 (de) | Pharmazeutische zubereitung und methode diese zu verabreichen | |
AU2007307639B2 (en) | Method and apparatus for occluding a lumen | |
US8197461B1 (en) | Controlled release system for delivering therapeutic agents into the inner ear | |
RU2687596C2 (ru) | Многоблочные устройства для доставки лекарственного средства и способы доставки лекарственного средства | |
JP4953571B2 (ja) | 動脈瘤を処置するための方法およびデバイス | |
KR101689786B1 (ko) | 남성 비뇨생식기 및 주위 조직을 치료하는 방법 및 체내이식형 약물 전달 장치 | |
AU742061B2 (en) | Device for local administration of solid and semisolid formulations, sustained-release formulations for parenteral administration and method of preparation | |
RU2606662C2 (ru) | Устройства и способы для расширения отверстия придаточной пазухи носа и для лечения синусита | |
EP2490632B1 (de) | Verhütungsvorrichtungen | |
RU2008143224A (ru) | Имплантанты назолакримальной дренажной системы для медикаментозной терапии | |
WO2007030512A3 (en) | Graft implant containing drug crystals | |
CN107249475A (zh) | 用于封闭脉管中的经皮开口的闭合装置 | |
JP6743041B2 (ja) | 上部尿路への薬剤の局所的な送達装置及び方法 | |
CN105013072B (zh) | 用于子宫的带药缓释装置 | |
CN204864514U (zh) | 用于子宫的带药缓释装置 | |
WO2006000272A2 (de) | Vorrichtung zur gezielten freisetzung von stoffen in einem hohlraum | |
CN116113447A (zh) | 用于治疗包括鼻出血的体腔或空间出血的装置及其制造和使用方法 | |
CN204815327U (zh) | 用于子宫的带药缓释装置 | |
WO2017155866A1 (en) | Osmotic therapeutic agent delivery device | |
KR100554519B1 (ko) | 혈관지혈구 | |
KR20240089599A (ko) | 고용량 약물 전달 장치 | |
JP2014050535A (ja) | 医療用デバイスおよび取付装置 | |
WO2009130265A2 (en) | Medical device |